I
nflammatory bowel diseases (IBDs), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic disabling disorders that can alter quality of life. 1, 2 Mucosal healing is recognized hitherto as the best therapeutic endpoint in IBD, as it was associated with sustained clinical remission, reduced rates of hospitalization, and decreased risk of surgery. [3] [4] [5] [6] [7] [8] Repeated colonoscopies are consequently warranted to tightly monitor mucosal inflammation and to adapt the therapeutic strategy. [9] [10] [11] Because of the burden induced by the repeat of such an examination for the patients, including the risk of potential complications (especially perforations), 11 alternative tools have been developed in the last decade for the monitoring of IBD.
Flexible rectosigmoidoscopy is highly correlated with colonoscopy for UC activity assessment and is often preferred to avoid general anesthesia. 12 C-reactive protein dosage is the most used serological biomarker. Although the absolute value of C-reactive protein could be normal even in the presence of ulceration, 13 C-reactive protein normalization is associated with favorable clinical outcomes in patients treated with biologics. 14, 15 The measurement of inflammatory proteins in the stools is an attractive option. Fecal calprotectin is considered as the most effective fecal biomarker to detect endoscopic activity in IBD. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] In the last decade, some authors reported that fecal calprotectin was correlated with endoscopic scores and was able to detect endoscopic ulceration in IBD. [30] [31] [32] [33] Cross-sectional imaging is another alternative option to monitor patients with CD. In this context, magnetic resonance enterocolonography (MRE), performed with no enteroclysis, no bowel cleansing the day before the examination and no rectal enema, demonstrated high accuracy in CD and is preferred to CT because of its lack of ionizing radiations. [34] [35] [36] [37] [38] Bowel ultrasonography is another tool for evaluation of CD activity in terms of complications, postoperative recurrence, and monitoring response to medical therapy. 39 Finally, wireless capsule endoscopy (WCE) is an accurate tool to diagnose CD involving the small bowel and to assess inflammatory activity. [40] [41] [42] All these monitoring tools are considered as minimally invasive by IBD physicians but their real discomfort according to the patients' feeling remains poorly investigated.
This study aimed to compare the acceptability and the perceived clinical utility of these monitoring tools according to IBD patients' opinion.
MATERIALS AND METHODS

Ethical Considerations
The study was performed in accordance with the Declaration of Helsinki, Good Clinical Practice and applicable regulatory requirements. The study was approved by the local Ethics Committee (IRB#00008526ref2015/CE66).
Questionnaires and Patients
A first version of the questionnaire was developed by the scientific committee of the ACCEPT study (A.B., F.G., and G.B.).
This first version was then submitted to an external reviewer (L.P.-B.) leading to minor corrections. The preliminary phase, including 20 patients, was performed in the University Hospital Estaing of Clermont-Ferrand, France, to confirm the feasibility of the questionnaire. After this preliminary phase, the final questionnaire was composed of 2 parts: a self-administered questionnaire and a physician questionnaire filled out independently. In the first part, the patient indicated demographics and evaluated the acceptability and the perceived utility of each monitoring tool using visual analog scales (VAS). We decided to use VAS as no other tool has been validated in this indication. VAS ranged from 0 (absolutely unacceptable or useless) to 10 (totally acceptable or useful). VAS was requested for venipuncture, stools collection, colonoscopy, rectosigmoidoscopy, MRE, ultrasonography, and WCE for patients with CD, whereas VAS was collected only for venipuncture, stools collection, colonoscopy, and rectosigmoidoscopy for patients with UC. The patients were asked to evaluate acceptability and utility using VAS, only for the examinations that they have previously undergone. In addition, the patients were questioned about the factors that decreased the acceptability of each monitoring tool. The second part (filled out by the physician) collected patients' demographics, Montreal classification, 43 concomitant therapies for IBD, and clinical score (Harvey Bradshaw Index for CD and Simple Clinical Colitis Activity Index for UC). 44 Active disease was defined by a Harvey Bradshaw Index above 4 for CD and a Simple Clinical Colitis Activity Index above 2 for UC.
Patients with an established diagnosis of IBD for at least 3 months have been prospectively and consecutively included during 6 weeks (between June 1, 2015, and July 14, 2015) . This study took place in 20 French centers encompassing 9 university hospitals and 11 private centers.
Statistical Analysis
Statistical analyses were performed using Stata software, version 13 (StataCorp, College Station, TX). The tests were 2-sided, with a ¼ 0.05. Patient's characteristics were described as mean 6 SD or median and interquartile range (IQR) for continuous variables, according to statistical distribution (normality assessed using the Shapiro-Wilk test), and as the number of patients (%) for categorical variables. VAS were expressed as median with IQR. Comparisons between independent groups were performed using Chi-squared or Fisher's exact tests for categorical variables and analysis of variance or Kruskal-Wallis tests if assumptions of analysis of variance are not met ( [1] normality and [2] homoscedasticity studied using the Bartlett's test) for quantitative parameters. When appropriate, a suitable post hoc test was applied for multiple comparisons: Tukey-Kramer after analysis of variance or Dunn test after Kruskal-Wallis. Then, a regression linear model for continuous dependent variable was performed in multivariate situation using backward and forward stepwise regression on the factors considered significant in univariate analysis. The normality of residuals was studied as described previously. When appropriate, a logarithmic transformation of dependent outcome has been proposed. Finally, in paired context (comparisons as utility versus acceptability), paired t test or Wilcoxon test was used for quantitative variables and Stuart-Maxwell for categorical parameters.
RESULTS
Characteristics of the Patients
Of the 923 collected questionnaires, 916 were suitable for the analysis. Patients' characteristics are given in Table 1 . Overall, our cohort included 618 patients with CD. Among them, 36.6% were male and 34.0% had undergone a previous CD-related surgery. The mean disease duration was 12.0 6 13.0 years. Among the 298 patients with UC included in our cohort, 48.5% were male, and the mean disease duration was 14.7 6 21.9 years. According to the clinical scores, 34.2% and 39.5% of the patients experienced active disease at the time of the study in CD and UC, respectively.
Acceptability of Monitoring Tools in the Overall IBD Population
Patients with CD
Considering patients with CD, the distribution and the median of acceptability VAS for each monitoring tool are presented in Figure 1 . (Fig. 2A) .
Patients with UC
The distribution and the median VAS of acceptability for each monitoring tool are presented in Figure 3 . (Fig. 4A ).
Factors Associated with Acceptability
From the first part of the questionnaire filled out by the patients, the main factors leading to decrease the acceptability for each monitoring tool were retrieved ( Table 2 ). The pain (22.2%) and the risk of complications such as ecchymosis and infection (16.5%) are the main factors decreasing the acceptability of venipuncture. Stools collection acceptability was impacted by the embarrassment to collect the stools (43.0%), the dirtiness feeling (23.0%), and the problem of transporting the sample (17.7%). The major drawbacks for colonoscopy were bowel cleansing (76.3%) and risk of complications, especially perforation (20.6%). Discomfort (bloating and pain) (51.3%), embarrassment to undergo the examination (31.3%), and the need for rectal enema (36.6%) were described as negative factors for rectosigmoidoscopy. Acceptability for performing MRE was decreased by the use of polyethylene glycol ingestion to achieve bowel distension (48.3%) leading to potential diarrhea (35.0%) or vomiting (33.7%) and the need for peripheral vein installation and gadolinium injection (14.0%). No factor was notified by the patients as limiting the acceptability of ultrasonography. The main factors decreasing WCE acceptability were the risk of capsule retention (21.4%), the need for bowel cleansing (20.0%), and the difficulty to swallow the capsule (15.5%).
We investigated the factors associated with decrease acceptability of each monitoring tool in univariate and multivariate analyses. The factors associated with lower VAS values are detailed in Table 2 . The 3 independent factors associated with a decreased acceptability of colonoscopy were female sex, young age at diagnosis, and education level higher than baccalaureate. Female sex, long period elapsed since undergoing the examination, patients with CD, and active disease were associated with decreased acceptability of rectosigmoidoscopy. Female sex had also a negative impact on acceptability of WCE, ultrasonography, and stools collection. Finally, ultrasonography was more acceptable for patients with private practice monitoring.
Perceived Clinical Utility of Monitoring Tools in the Overall IBD Population
Patients with CD
The distribution and the median of utility VAS for each monitoring tool are presented in (Fig. 2B) .
UC
The distribution and the median of utility VAS for each monitoring tool are presented in Figure 1 . All the monitoring tools, i.e., venipuncture, stools collections, colonoscopy, and rectosigmoidoscopy, demonstrated similar utility for the patients with VAS of 9.3 IQR (8.8-9.7), 9.0 IQR (7.1-9.6), 9.2 IQR (8.0-9.6), and 8.9 IQR (7.0-9.5), respectively (Fig. 4B) .
Concordance Between Acceptability and Perceived Clinical Utility in Patients with IBD
Considering the overall patients with IBD, we observed moderate or substantial concordance between acceptability and perceived clinical utility in IBD patients with coefficient ranging from 0.55 to 0.76 (Figs. 1 and 3) , whereas colonoscopy demonstrated the lowest concordance (from 0.46 to 0.51) (Figs. 1 and 3 ).
DISCUSSION
To our knowledge, this study is the first to investigate acceptability and perceived utility of the monitoring tools in a large nationwide cohort of 923 patients with IBD. Many researches are currently focusing on the development of minimally invasive technics to follow patients with IBD aiming to reduce the burden experienced by the patients. However, the opinions differ between patients and physicians to define the noninvasive nature of each tool.
For patients with IBD, endoscopy was the least appreciated procedure. Among them, flexible rectosigmoidoscopy is by far the least accepted. In clinical practice, IBD physicians performed rectosigmoidoscopy rather than colonoscopy to monitor patients with UC because of its accessibility, rapidity, and the absence of anesthesia. In addition, a high agreement between rectosigmoidoscopy and colonoscopy has been recently shown for disease activity assessment and mucosal healing in patients with UC. 12 By contrast, patients with IBD would choose colonoscopy rather than rectosigmoidoscopy. For most patients (82.8%), the need for general anesthesia was not a drawback, whereas abdominal discomfort (51.3%) and embarrassment (31.3%) represented majors concerns for flexible rectosigmoidoscopy. More than one-third of the patients disagreed with the use of rectal enema before rectosigmoidoscopy with the feeling of unclear utility especially for patients experiencing flares. As expected, bowel cleansing had a negative impact on colonoscopy acceptability (76.3% of the patients), and efforts have to be done to replace historical bowel cleansing. In our cohort, patients with CD considered MRE as significantly more acceptable than colonoscopy. It was in line with a previous study including 31 patients with CD comparing these 2 modalities. 45 The authors reported that most of the patients (29/31) prefer MRE for the next examination. They observed that bowel distension used for MRE was significantly less burdensome than bowel cleansing for colonoscopy. 45 In another small sample size study, a majority of the 18 patients, including 10 patients with IBD, preferred MRE performed with rectal enema (1.5 L of water) to colonoscopy. 46 Although some teams proposed to maintain bowel cleansing the day before MRE and rectal enema during the examination, 35, 36 it has been clearly shown that it is not warranted. Performing MRE with no bowel cleansing and no rectal enema does not alter the MRE performances in evaluating inflammatory activity or detecting endoscopic ulcerations 37, 38, 47 and highly improves its acceptability. 48 Further research is needed to find alternative modalities of polyethylene glycol for bowel distension as suggested by this cohort. Ultrasonography is the most acceptable examination to assess small bowel inflammation in CD. Unfortunately, the operator-dependent characteristics and the difficulties to explore the overall bowel length are known limiting factors of ultrasound. Novel modalities of ultrasonography could counterbalance these weaknesses in the near future. The strong acceptability of ultrasound encourages the development of future research to assess the value of ultrasound for IBD monitoring. WCE and MRE were well-accepted tools for patients with CD. In addition, WCE did not demonstrate a significant higher acceptability than MRE. In a previous study including 38 patients with known or suspected CD, WCE was significantly favored over MRE with enteroclysis with respect to bowel preparation and swallowing of the capsule (compared with insertion of the tube/scope). 49 The use of enteroclysis could partly explain these findings. However, Lahat et al 50 compared patients' tolerance and preference to MRE with no enteroclysis versus WCE in 56 patients with CD. Before examination discomfort, during-examination discomfort, nausea, vomiting, bloating, and abdominal pain were all significantly more prominent in MRE as compared to WCE. 50 Seventy-eight percentage of patients (44 patients) preferred to repeat CE as compared to 22% (P ¼ 0.0001) who preferred MRE. 50 Once again, this underlines the detrimental impact of the use of polyethylene glycol or mannitol for bowel distension before MRE. WCE should be more widely used in daily practice regarding its well acceptability and its reliability.
Although stools collection was more acceptable than endoscopic procedures, it was surprisingly less acceptable than MRE or WCE for patients with CD. Stools collection acceptability was impacted by the embarrassment to collect the stools (43.0%), the dirtiness feeling (23.0%), and the problem to transport the sample (17.7%). Investigations should be led to facilitate samples collection and transportation, as it was done for fecal immunochemical test during colorectal cancer screening. Venipuncture was overall the most acceptable examination. Unfortunately, serum biomarkers are mainly not gut specific and are considered as adjunctive tools. 51 Patients with IBD considered that all IBD monitoring tools are very useful except rectosigmoidoscopy for patients with CD. It probably reflects the very strong confidence relationship between patients with IBD and their physicians.
Several strengths have to be underlined in this study. It was the largest cohort reported hitherto (916 patients and 20 centers sharing referral centers and private practice) which compare all the IBD monitoring modalities in the same cohort. In addition, the questionnaire was developed using a reliable methodology.
In conclusion, serum or fecal biomarkers, WCE, MRE and ultrasonography have been identified by patients with IBD as more acceptable modalities than endoscopic procedures. The identification using a rigorous scientific approach of the strengths and the perceived weaknesses of such examinations should lead to an improvement in the acceptability of these monitoring tools. This study was an essential step to improve the information delivered to the patients, to optimize follow-up adherence of the patients, and to maximize the use of the current IBD monitoring tools.
